PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS

Aim. To perform pharmacoeconomic analysis of CHF therapy with supramolecular sacubitril/valsartan complex compared to routine therapy in patients with diabetes type 2 and ACE inhibitor intolerance within context of Russian healthcare system.Material and methods. A Markov model based on Russian Stand...

Full description

Bibliographic Details
Main Authors: S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
Format: Article
Language:English
Published: Столичная издательская компания 2018-05-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
sacubitril/valsartan
heart failure
diabetes
pharmacoeconomics
cost-effectiveness analysis
budget impact analysis
Online Access:https://www.rpcardio.online/jour/article/view/1644

Internet

https://www.rpcardio.online/jour/article/view/1644

Similar Items